[company_age]5.0[/company_age][employees]11-50 employees[/employees][funding]Pre seed[/funding][description]TissueLabs is a pioneering company dedicated to revolutionizing the field of organ fabrication. Founded by a team of passionate and driven individuals, including medical doctors and engineers, the company is driven by a singular mission: to create the world's first transplantable bioartificial heart. This ambitious goal stems from a personal desire to address the critical need for organ transplantation and alleviate the suffering caused by organ failure.\n\nTissueLabs distinguishes itself from competitors by its unwavering commitment to innovation and its unique approach to biofabrication. The company's team comprises leading experts who constantly push the boundaries of technology, developing novel methods and solutions to overcome the most challenging obstacles in the field. This dedication to innovation is evident in their commercially available products, which empower the scientific community to create a diverse range of tissues and organs.\n\nUnlike traditional companies that focus solely on research and development, TissueLabs prioritizes accessibility and collaboration. By making their cutting-edge technology readily available, they empower researchers and scientists worldwide to contribute to the advancement of organ fabrication. This collaborative approach fosters a vibrant ecosystem of innovation and accelerates progress towards the ultimate goal of creating transplantable organs.\n\nTissueLabs' unwavering ambition and relentless pursuit of innovation set them apart as a truly exceptional company. Their dedication to tackling a critical global challenge, coupled with their collaborative spirit and commitment to accessibility, positions them as a leader in the field of biofabrication with the potential to revolutionize the future of medicine.[/description][ps]Bioprinters, bioinks, and accessories for creating tissues and organs in the lab.[/ps]